Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics

Patients Dispensed Medications with Actionable Pharmacogenomic Biomarkers: Rates and Characteristics https://t.co/adQGzxLkXa

Check this article which goal was to assess the potential of knowing patients' genomic characteristics into prescribing practices by @nature https://t.co/6pwM7uVyG9 @PGx_FFUL #expectuseveryday #everydayisagenomicday

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

RT @GIMJournal: Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? ht…

Curious about the potential for incorporating knowledge of patients’ genomic characteristics into prescribing practices? https://t.co/V6yDFEpJ63 #pharmacogenomics #Genetics #Genomics https://t.co/ydFkQfCjUD

RT @mandl: 18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medic…

RT @ngehlenborg: Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical in…

RT @mandl: 18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medic…

RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…

RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…

RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…

RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…

RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…

RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…

RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…

RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…

RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…

RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…

https://t.co/zk3pIPzFhu

RT @annewoj23: Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to ben…

Pharmacogenomics is not integrated into the normal practice of medicine but there is a huge opportunity for all of us to benefit if it was. @23andMe has two pharmacogenetic @FDA authorizations. By empowering customers, we have the best chance to change me

RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…

RT @chrissyfarr: Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on thei…

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…

RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…

RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…

RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…

RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

Bravo @smanzi2 ... fantastic work.

RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…

RT @mandl: Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescrib…

Yes. Not only do we find 63% of adults are prescribed a med with pharmacogenomic indications on the label, 18% them are prescribed a second such medication, increasing the risk of toxicity. Despite @US_FDA recommendations, these genomic indicators are ra

RT @mandl: 18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medic…

Fascinating research on pharmacogenomics, finding that the number of people who may benefit from prescribing based on their genomics is "substantial." But many barriers remain: https://t.co/3GsU4G6siO

Measuring the gap - how often are medications prescribed where gene-based guidance might be available? Often - and note pharmacogenomic guidance will continue to grow, so the gap will widen if we don’t act. From team led by @dianboliu, senior @mandl

RT @mandl: 18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medic…

18% of patients prescribed medications with recommended gene-based prescribing modifications, are prescribed a second such medication. Not measuring and acting on pharmacogenomics increases risk of toxicity and adverse events, particularly when the metab

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

RT @ngehlenborg: Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical in…

RT @ngehlenborg: Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical in…

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

RT @ngehlenborg: Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical in…

Great work by a #harvardMBI alumnus! If you want to enter the rapidly evolving and highly impactful world of biomedical informatics you can still apply to our Master’s program until February 5th: https://t.co/P4c96Lb4JW

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

RT @mandl: Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications.…

Establishing a need for genomically-informed medicine.

Over two years, 63% of adults & 29% of children are dispensed medications with recommended gene-based prescribing modifications. Pharmacogenomic-guided prescribing is low hanging fruit for improving medication safety. @GIMJournal @smanzi2 @DianboLi